# GO_biological_process_0038

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `GO_biological_process`  
**Author expected answer:** **D** — defense response to virus

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MNLTLDHTTLHRAAKYFMDSGKAASHEAAMNLLQQFGLTIYVGEEIRSSAAHQIALLTIVNVTRRTLLGGVEVIGLPDCDSLTALAPNTGLKEAVMALGGTPVAVARPEWPTALIGSVEDYSNKDTAWRVTWEGWRAGAAPLMIGDRLSEDNSMALAPALAAAVCAGEVFSHYAGDHPMAGRRTAGLSLWQPGADWLDVDESEPELAFLPSNLWIIGLGNLGQAFAWLLALMPYETPQELQLVLQDYDRIAPSNDSTSLLSYKHDTNKMKARVVADWLDKRGFTTFIEERRFGPWTKRHADEPGVALCGVDNALARSALDQAGFPLIVEAGLGGGPQAFRSLGIHTFPSSRTAAEIWAKQVALADTSTEDMPAYQALKKSGIDACGLTQLASRTVGVPFVGLIAACLAMSELLRRLHGGKAFEFIAGSTATLQDIEFGTLHAPPYAHGYTRAMPMGWPTAP

[Multiple Choices]
A. swimming behavior
B. [2Fe-2S] cluster assembly
C. pre-miRNA processing
D. defense response to virus
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Biological Process Prediction, which is to predict the primary biological process a given protein participates in, as defined by the Gene Ontology (GO) 'Biological Process' branch. A biological process is a series of molecular events that accomplishes a larger biological program, such as cell division or signal transduction. Based on the provided protein sequence, you must select the option that best describes the overall biological objective to which the protein contributes.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The supplied sequence exactly matches the historical and current UniProt record for BilD. That record identifies BilD as part of a bacterial antiviral defense system, and assigns it the GO term “defense response to virus” with IDA evidence. The function annotation is linked to a cited experimental study; it describes BilD’s role in ubiquitin-like conjugation that interferes with phage assembly.

Citations as saved: [H3](#evidence-h3), [H5](#evidence-h5), [C5](#evidence-c5), [C7](#evidence-c7).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is a long, soluble bacterial enzyme-like protein, which does not by itself establish a role in antiviral defense. General sequence-level reasoning cannot identify the specific Bil system or its phage-targeting function.


**Missing item-specific fact**

> The protein-specific fact that this sequence is BilD, an E1-like component of the Bil antiviral defense system, is needed to select D.


**Reason**

> The supporting identification and functional evidence are external, protein-specific annotations, not information given in the question. Recognizing the exact sequence or recalling its database record would be lookup or memorization, not reasoning from the supplied input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The matched protein-specific annotation supports D. The other choices do not have comparable support in the supplied evidence.


### Important caveats

- The accession and annotations are reviewer-only evidence and were not supplied to the evaluated model.
- The experimental source supports the Bil system’s antiviral activity; some mechanistic details in the function annotation are explicitly described as probable.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is a long, soluble bacterial enzyme-like protein, which does not by itself establish a role in antiviral defense. General sequence-level reasoning cannot identify the specific Bil system or its phage-targeting function.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific fact that this sequence is BilD, an E1-like component of the Bil antiviral defense system, is needed to select D.",
    "reason": "The supporting identification and functional evidence are external, protein-specific annotations, not information given in the question. Recognizing the exact sequence or recalling its database record would be lookup or memorization, not reasoning from the supplied input."
  },
  "case_id": "GO_biological_process_0038",
  "expected_answer_check": {
    "evidence_ids": [
      "H3",
      "H5",
      "C5",
      "C7"
    ],
    "judgment": "supported",
    "reason": "The supplied sequence exactly matches the historical and current UniProt record for BilD. That record identifies BilD as part of a bacterial antiviral defense system, and assigns it the GO term “defense response to virus” with IDA evidence. The function annotation is linked to a cited experimental study; it describes BilD’s role in ubiquitin-like conjugation that interferes with phage assembly."
  },
  "important_caveats": [
    "The accession and annotations are reviewer-only evidence and were not supplied to the evaluated model.",
    "The experimental source supports the Bil system’s antiviral activity; some mechanistic details in the function annotation are explicitly described as probable."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched protein-specific annotation supports D. The other choices do not have comparable support in the supplied evidence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_biological_process_0038",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The supplied sequence exactly matches the historical and current UniProt record for BilD. That record identifies BilD as part of a bacterial antiviral defense system, and assigns it the GO term “defense response to virus” with IDA evidence. The function annotation is linked to a cited experimental study; it describes BilD’s role in ubiquitin-like conjugation that interferes with phage assembly.",
    "evidence_ids": ["H3", "H5", "C5", "C7"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is a long, soluble bacterial enzyme-like protein, which does not by itself establish a role in antiviral defense. General sequence-level reasoning cannot identify the specific Bil system or its phage-targeting function.",
    "missing_item_specific_fact": "The protein-specific fact that this sequence is BilD, an E1-like component of the Bil antiviral defense system, is needed to select D.",
    "reason": "The supporting identification and functional evidence are external, protein-specific annotations, not information given in the question. Recognizing the exact sequence or recalling its database record would be lookup or memorization, not reasoning from the supplied input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched protein-specific annotation supports D. The other choices do not have comparable support in the supplied evidence."
  },
  "important_caveats": [
    "The accession and annotations are reviewer-only evidence and were not supplied to the evaluated model.",
    "The experimental source supports the Bil system’s antiviral activity; some mechanistic details in the function annotation are explicitly described as probable."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The protein is BilD (UniProt A0A1I1P074, sequence matched, 461 AA), annotated with GO:0051607 'defense response to virus' at evidence code IDA (Inferred by Direct Assay) from PubMed:39020165 (Nature 2024). The FUNCTION comment describes BilD as the E1 component of the Bil bacterial ISG15-like antiviral defense system that conjugates ubiquitin-like BilA to bacteriophage tail fiber proteins, interfering with phage assembly. Experimental phage-resistance assays (~100-fold resistance to multiple phages) confirm the antiviral role. The sequence and annotation match exactly.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [C7](#evidence-c7), [H3](#evidence-h3), [H4](#evidence-h4), [H5](#evidence-h5).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A model could partially eliminate distractors: option C (pre-miRNA processing) is a eukaryotic-specific process incompatible with a bacterial protein; option A (swimming behavior) lacks any flagellar/motility sequence features; option B (&#91;2Fe-2S&#93; cluster assembly) lacks canonical Fe-S cluster-binding motifs. However, recognizing the sequence as an E1-like adenylation/thioester-forming enzyme would point toward generic 'protein modification by small protein conjugation,' not specifically 'defense response to virus.' The link between this E1-like conjugation enzyme and antiviral defense is not a general inference from sequence features—it requires knowledge that BilD is the E1 of the Bil system, which specifically targets bacteriophage structural proteins.


**Missing item-specific fact**

> The identification of this protein as the E1 component of the Bil (bacterial ISG15-like) antiviral defense system, published in 2024 (PubMed:39020165), is an item-specific annotation. Without knowing the Bil system, the E1-like sequence features alone do not distinguish 'defense response to virus' from other ubiquitin-like conjugation pathways.


**Reason**

> While distractors C, A, and B can be partially ruled out by general biological reasoning (eukaryotic-only process, absent motility features, absent Fe-S motifs), the positive assignment to 'defense response to virus' for a bacterial E1-like protein cannot be derived from sequence features alone. The E1-like adenylation and thioester-forming architecture is shared with many non-antiviral conjugation systems. The specific antiviral role requires memorization of the 2024 Bil system discovery.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the four given choices, D is the only one consistent with the experimental annotation. C is eukaryotic-specific, A lacks any motility features, and B lacks Fe-S cluster motifs. No alternative among the provided options is defensible for this protein.


### Important caveats

- The Bil system was described in a 2024 Nature paper; the UniProt entry was first public in April 2025. Models with training cutoffs before 2024 would have no prior knowledge of this system.
- The GO annotation uses IDA (Inferred by Direct Assay) from PubMed:39020165, indicating experimental rather than purely computational evidence.
- The sequence is a 461-aa bacterial protein; recognizing E1-like adenylation/thioester features from raw sequence without domain-specific knowledge is non-trivial.
- The reviewer-only evidence was absent from the evaluated model input; the model saw only the raw sequence and four GO term labels.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A model could partially eliminate distractors: option C (pre-miRNA processing) is a eukaryotic-specific process incompatible with a bacterial protein; option A (swimming behavior) lacks any flagellar/motility sequence features; option B ([2Fe-2S] cluster assembly) lacks canonical Fe-S cluster-binding motifs. However, recognizing the sequence as an E1-like adenylation/thioester-forming enzyme would point toward generic 'protein modification by small protein conjugation,' not specifically 'defense response to virus.' The link between this E1-like conjugation enzyme and antiviral defense is not a general inference from sequence features—it requires knowledge that BilD is the E1 of the Bil system, which specifically targets bacteriophage structural proteins.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The identification of this protein as the E1 component of the Bil (bacterial ISG15-like) antiviral defense system, published in 2024 (PubMed:39020165), is an item-specific annotation. Without knowing the Bil system, the E1-like sequence features alone do not distinguish 'defense response to virus' from other ubiquitin-like conjugation pathways.",
    "reason": "While distractors C, A, and B can be partially ruled out by general biological reasoning (eukaryotic-only process, absent motility features, absent Fe-S motifs), the positive assignment to 'defense response to virus' for a bacterial E1-like protein cannot be derived from sequence features alone. The E1-like adenylation and thioester-forming architecture is shared with many non-antiviral conjugation systems. The specific antiviral role requires memorization of the 2024 Bil system discovery."
  },
  "case_id": "GO_biological_process_0038",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "C7",
      "H3",
      "H4",
      "H5"
    ],
    "judgment": "supported",
    "reason": "The protein is BilD (UniProt A0A1I1P074, sequence matched, 461 AA), annotated with GO:0051607 'defense response to virus' at evidence code IDA (Inferred by Direct Assay) from PubMed:39020165 (Nature 2024). The FUNCTION comment describes BilD as the E1 component of the Bil bacterial ISG15-like antiviral defense system that conjugates ubiquitin-like BilA to bacteriophage tail fiber proteins, interfering with phage assembly. Experimental phage-resistance assays (~100-fold resistance to multiple phages) confirm the antiviral role. The sequence and annotation match exactly."
  },
  "important_caveats": [
    "The Bil system was described in a 2024 Nature paper; the UniProt entry was first public in April 2025. Models with training cutoffs before 2024 would have no prior knowledge of this system.",
    "The GO annotation uses IDA (Inferred by Direct Assay) from PubMed:39020165, indicating experimental rather than purely computational evidence.",
    "The sequence is a 461-aa bacterial protein; recognizing E1-like adenylation/thioester features from raw sequence without domain-specific knowledge is non-trivial.",
    "The reviewer-only evidence was absent from the evaluated model input; the model saw only the raw sequence and four GO term labels."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the four given choices, D is the only one consistent with the experimental annotation. C is eukaryotic-specific, A lacks any motility features, and B lacks Fe-S cluster motifs. No alternative among the provided options is defensible for this protein."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_biological_process_0038",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The protein is BilD (UniProt A0A1I1P074, sequence matched, 461 AA), annotated with GO:0051607 'defense response to virus' at evidence code IDA (Inferred by Direct Assay) from PubMed:39020165 (Nature 2024). The FUNCTION comment describes BilD as the E1 component of the Bil bacterial ISG15-like antiviral defense system that conjugates ubiquitin-like BilA to bacteriophage tail fiber proteins, interfering with phage assembly. Experimental phage-resistance assays (~100-fold resistance to multiple phages) confirm the antiviral role. The sequence and annotation match exactly.",
    "evidence_ids": ["C5", "C6", "C7", "H3", "H4", "H5"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A model could partially eliminate distractors: option C (pre-miRNA processing) is a eukaryotic-specific process incompatible with a bacterial protein; option A (swimming behavior) lacks any flagellar/motility sequence features; option B ([2Fe-2S] cluster assembly) lacks canonical Fe-S cluster-binding motifs. However, recognizing the sequence as an E1-like adenylation/thioester-forming enzyme would point toward generic 'protein modification by small protein conjugation,' not specifically 'defense response to virus.' The link between this E1-like conjugation enzyme and antiviral defense is not a general inference from sequence features—it requires knowledge that BilD is the E1 of the Bil system, which specifically targets bacteriophage structural proteins.",
    "missing_item_specific_fact": "The identification of this protein as the E1 component of the Bil (bacterial ISG15-like) antiviral defense system, published in 2024 (PubMed:39020165), is an item-specific annotation. Without knowing the Bil system, the E1-like sequence features alone do not distinguish 'defense response to virus' from other ubiquitin-like conjugation pathways.",
    "reason": "While distractors C, A, and B can be partially ruled out by general biological reasoning (eukaryotic-only process, absent motility features, absent Fe-S motifs), the positive assignment to 'defense response to virus' for a bacterial E1-like protein cannot be derived from sequence features alone. The E1-like adenylation and thioester-forming architecture is shared with many non-antiviral conjugation systems. The specific antiviral role requires memorization of the 2024 Bil system discovery."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the four given choices, D is the only one consistent with the experimental annotation. C is eukaryotic-specific, A lacks any motility features, and B lacks Fe-S cluster motifs. No alternative among the provided options is defensible for this protein."
  },
  "important_caveats": [
    "The Bil system was described in a 2024 Nature paper; the UniProt entry was first public in April 2025. Models with training cutoffs before 2024 would have no prior knowledge of this system.",
    "The GO annotation uses IDA (Inferred by Direct Assay) from PubMed:39020165, indicating experimental rather than purely computational evidence.",
    "The sequence is a 461-aa bacterial protein; recognizing E1-like adenylation/thioester features from raw sequence without domain-specific knowledge is non-trivial.",
    "The reviewer-only evidence was absent from the evaluated model input; the model saw only the raw sequence and four GO term labels."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A1I1P074` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 13. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1P074.json)  
**Locator:** `/comments/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:37.902008+00:00.  

```json
{"commentType":"FUNCTION","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"39020165","source":"PubMed"},{"evidenceCode":"ECO:0000305","id":"39020165","source":"PubMed"}],"value":"Component of the Bil (bacterial ISG15-like) antiviral defense system, composed of BilA, BilB, BilC and BilD. The Bil system specifically conjugates a ubiquitin-like moiety (bilA) to the bacteriophage central tail fiber (CTF, or tip attachment protein J) via reactions involving E1 (bilD) and E2 (bilB). Modifies CTF of phage SECphi27 and SECphi4, which probably interferes with assembly of the phage tail. Also modifies T5 baseplate hub protein pb3 (gene D16), but not gp27 of phage T6 (Bil defends against T6). BilD (E1) catalyzes the first step in conjugation (PubMed:39020165). Activates ubiquitin-like BilA by first adenylating its C-terminal glycine residue with ATP, and then conjugates it to the side chain of a cysteine residue in E1 (this protein), yielding a ubiquitin-E1 thioester and free AMP (Probable) (PubMed:39020165). Bil-encoding bacteria produce mostly defective phage SECphi27, many of which have phage assembly defects, including no tails. SECphi27 phage progeny produced in E.coli with the Bil system inject less DNA into naive host cells, maybe because the phage are less able to adsorb and inject their DNA into host cells"}]}
```

Source SHA-256: `85e7a104b9ec3fed02e35ea4232cf86a383df56f7435a81173e8fa183bf247be`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1P074.json)  
**Locator:** `/comments/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:37.902008+00:00.  

```json
{"commentType":"FUNCTION","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"39020165","source":"PubMed"}],"value":"Expression of the Bil system in E.coli (strain MG1655) confers about 100-fold resistance to phage SECphi27, SECphi18, SECphi6, SECphi4 and T5, but not to SECphi17. When cells expressing the Bil system are infected by phage SECphi27 at low multiplicity of infection (0.03 MOI) the culture survives, at 3.0 MOI the culture collapses at the same time as cells without the Bil system"}]}
```

Source SHA-256: `85e7a104b9ec3fed02e35ea4232cf86a383df56f7435a81173e8fa183bf247be`.

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1P074.json)  
**Locator:** `/uniProtKBCrossReferences/7`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:37.902008+00:00.  

```json
{"database":"GO","evidences":[{"evidenceCode":"ECO:0000314","id":"39020165","source":"PubMed"}],"id":"GO:0051607","properties":[{"key":"GoTerm","value":"P:defense response to virus"},{"key":"GoEvidenceType","value":"IDA:UniProtKB"}]}
```

Source SHA-256: `85e7a104b9ec3fed02e35ea4232cf86a383df56f7435a81173e8fa183bf247be`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1I1P074?format=txt&versions=13)  
**Locator:** `lines 27-44`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 13 / 1.  
**Retrieved:** 2026-11-02T04:24:41.131133+00:00.  

```text
CC   -!- FUNCTION: Component of the Bil (bacterial ISG15-like) antiviral defense
CC       system, composed of BilA, BilB, BilC and BilD. The Bil system
CC       specifically conjugates a ubiquitin-like moiety (bilA) to the
CC       bacteriophage central tail fiber (CTF, or tip attachment protein J) via
CC       reactions involving E1 (bilD) and E2 (bilB). Modifies CTF of phage
CC       SECphi27 and SECphi4, which probably interferes with assembly of the
CC       phage tail. Also modifies T5 baseplate hub protein pb3 (gene D16), but
CC       not gp27 of phage T6 (Bil defends against T6). BilD (E1) catalyzes the
CC       first step in conjugation (PubMed:39020165). Activates ubiquitin-like
CC       BilA by first adenylating its C-terminal glycine residue with ATP, and
CC       then conjugates it to the side chain of a cysteine residue in E1 (this
CC       protein), yielding a ubiquitin-E1 thioester and free AMP (Probable)
CC       (PubMed:39020165). Bil-encoding bacteria produce mostly defective phage
CC       SECphi27, many of which have phage assembly defects, including no
CC       tails. SECphi27 phage progeny produced in E.coli with the Bil system
CC       inject less DNA into naive host cells, maybe because the phage are less
CC       able to adsorb and inject their DNA into host cells.
CC       {ECO:0000269|PubMed:39020165, ECO:0000305|PubMed:39020165}.
```

Source SHA-256: `a37af1ad780f0f67b0b403cc351978c7e209c2d02ee53894ad0fc5e2c09bea6a`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1I1P074?format=txt&versions=13)  
**Locator:** `lines 45-55`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 13 / 1.  
**Retrieved:** 2026-11-02T04:24:41.131133+00:00.  

```text
CC   -!- FUNCTION: Expression of the Bil system in E.coli (strain MG1655)
CC       confers about 100-fold resistance to phage SECphi27, SECphi18, SECphi6,
CC       SECphi4 and T5, but not to SECphi17. When cells expressing the Bil
CC       system are infected by phage SECphi27 at low multiplicity of infection
CC       (0.03 MOI) the culture survives, at 3.0 MOI the culture collapses at
CC       the same time as cells without the Bil system.
CC       {ECO:0000269|PubMed:39020165}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
```

Source SHA-256: `a37af1ad780f0f67b0b403cc351978c7e209c2d02ee53894ad0fc5e2c09bea6a`.

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1I1P074?format=txt&versions=13)  
**Locator:** `lines 63-63`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 13 / 1.  
**Retrieved:** 2026-11-02T04:24:41.131133+00:00.  

```text
DR   GO; GO:0051607; P:defense response to virus; IDA:UniProtKB.
```

Source SHA-256: `a37af1ad780f0f67b0b403cc351978c7e209c2d02ee53894ad0fc5e2c09bea6a`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_biological_process.json), zero-based source row 38. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
